Vittorio Timothy J, Lanier Gregg, Zolty Ronald, Sarswat Nitasha, Tseng Chi-Hong, Colombo Paolo C, Jorde Ulrich P
Zena and Michael A. Wiener Cardiovascular Institute, Mount Sinai School of Medicine, New York, NY 10029-6574, USA.
Echocardiography. 2010 Mar;27(3):294-9. doi: 10.1111/j.1540-8175.2009.01011.x. Epub 2010 Jan 11.
Impairment of flow-mediated, endothelium-dependent vasodilatation (FMD) of the brachial artery identifies peripheral endothelial dysfunction in subjects with chronic congestive heart failure (CHF) and is associated with increased morbidity and mortality. To further elucidate the interaction of peripheral and central mechanisms in the syndrome of CHF, we examined the association between endothelial function and chronotropic incompetence, an emerging prognostic marker in CHF.
Thirty subjects with stable New York Heart Association (NYHA) functional class II-III CHF were studied. A vascular ultrasound study was performed to measure brachial artery FMD. The percentage of age-adjusted maximal predicted heart rate (MPHR) reached during cardiopulmonary exercise tolerance testing (CPETT) was used to assess the degree of chronotropic competence. All patients received ACE inhibitors and beta-adrenoceptor blockers.
Brachial artery FMD averaged 1.3 +/- 2.4% and age-adjusted % MPHR 74.1 +/- 11.7%. FMD correlated with % MPHR among all patients (r = 0.60, P = 0.01). FMD and resting heart rate (RHR) did not significantly correlate (r = 0.13, P = 0.55).
FMD, a measure of peripheral endothelial dysfunction, and % MPHR, a central determinant of cardiac output, are moderately correlated in heart failure patients receiving optimal medical therapy. Whether a cause-effect relationship underlies this association remains to be investigated.
肱动脉血流介导的内皮依赖性血管舒张功能(FMD)受损可识别慢性充血性心力衰竭(CHF)患者的外周内皮功能障碍,且与发病率和死亡率增加相关。为进一步阐明CHF综合征中外周和中枢机制的相互作用,我们研究了内皮功能与变时性功能不全之间的关联,变时性功能不全是CHF中一种新出现的预后标志物。
对30例纽约心脏协会(NYHA)功能分级为II - III级的稳定CHF患者进行研究。进行血管超声检查以测量肱动脉FMD。心肺运动耐力测试(CPETT)期间达到的年龄校正最大预测心率(MPHR)百分比用于评估变时性功能的程度。所有患者均接受血管紧张素转换酶抑制剂和β肾上腺素能受体阻滞剂治疗。
肱动脉FMD平均为1.3±2.4%,年龄校正后的MPHR百分比为74.1±11.7%。在所有患者中,FMD与MPHR百分比相关(r = 0.60,P = 0.01)。FMD与静息心率(RHR)无显著相关性(r = 0.13,P = 0.55)。
在接受最佳药物治疗的心力衰竭患者中,作为外周内皮功能障碍指标的FMD与作为心输出量中枢决定因素的MPHR百分比呈中度相关。这种关联是否存在因果关系仍有待研究。